THE CORRELATION OF PREGNANCY COMPLICATIONS WITH C3/C4 LEVELS, ANTI-DSDNA TITERS, AND AUTOIMMUNE TARGET TESTING IN GRAVIDAS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective The purpose of this study was to evaluate the correlation between complement (C3 and C4) levels, anti-dsDNA titers, autoimmune target test (AITT), and pregnancy complications. Methods Ninety-three pregnancies with systemic lupus erythematosus (SLE) were analyzed retrospectively. We evaluated the course of the pregnancy and outcome, pregnancy complications, progression of SLE, maternal complications of SLE, drugs taken before and after pregnancy, neonatal outcomes, and C3/C4 levels, anti-dsDNA titers, and AITT results. SPSS ver. 14.0 was used for statistical analysis. The average and standard deviation are shown. Chi-square test and Pearson correlation test were used for statistical analysis. The significance level was set at 0.05. Results The C3 level was associated with maternal leukopenia, elevated serum C-reactive protein (CRP) elevation, hematuria, hypertension, and preterm premature rupture of membranes. The C4 level was associated with maternal proteinuria, hematuria, hematologic disease, and admission to the neonatal intensive care unit. The anti-dsDNA titer was associated with elevated maternal serum CRP, oligohydramnios,and neonatal anti-Sjögren's syndrome B (La) antibody. The AITT result was related to elevated erythrocyte sedimentation rate, and 1 and 5minute Apgar scores. Conclusion Our result show that adding the AITT to conventional C3/C4 and anti-dsDNA testing in gravidas with SLE might help antenatal care.
Abstract
Objective The purpose of this study was to evaluate the correlation between complement (C3 and C4) levels, anti-dsDNA titers, autoimmune target test (AITT), and pregnancy complications. Methods Ninety-three pregnancies with systemic lupus erythematosus (SLE) were analyzed retrospectively. We evaluated the course of the pregnancy and outcome, pregnancy complications, progression of SLE, maternal complications of SLE, drugs taken before and after pregnancy, neonatal outcomes, and C3/C4 levels, anti-dsDNA titers, and AITT results. SPSS ver. 14.0 was used for statistical analysis. The average and standard deviation are shown. Chi-square test and Pearson correlation test were used for statistical analysis. The significance level was set at 0.05. Results The C3 level was associated with maternal leukopenia, elevated serum C-reactive protein (CRP) elevation, hematuria, hypertension, and preterm premature rupture of membranes. The C4 level was associated with maternal proteinuria, hematuria, hematologic disease, and admission to the neonatal intensive care unit. The anti-dsDNA titer was associated with elevated maternal serum CRP, oligohydramnios,and neonatal anti-Sjögren's syndrome B (La) antibody. The AITT result was related to elevated erythrocyte sedimentation rate, and 1 and 5minute Apgar scores. Conclusion Our result show that adding the AITT to conventional C3/C4 and anti-dsDNA testing in gravidas with SLE might help antenatal care.
참고문헌 (39)
- Clark CA, "Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period", J Rheumatol, 32, pp.1709~1712 (2005)
- Rahman P, "Clinical predictors of fetal outcome in systemic lupus erythematosus", J Rheumatol, 25, pp.1526~1530 (1998)
- Carmona F, "Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus: a study of 60 cases", Eur J Obstet Gynecol Reprod Biol, 83, pp.137~142 (1999)
- Clark CA, "Preterm deliveries in women with systemic lupus erythematosus", J Rheumatol, 30, pp.2127~2132 (2003)
- Clowse ME, "A national study of the complications of lupus in pregnancy", Am J Obstet Gynecol, 199, pp.1~6 (2008)
- Briggs GG, "Drugs in pregnancy and lactation. 6th ed" (2002), Lippincott Williams & Wilkins
- Ruiz-Irastorza G, "Evaluation of systemic lupus erythematosus activity during pregnancy", Lupus, 13, pp.679~682 (2004)
- Clowse ME, "Lupus activity in pregnancy", Rheum Dis Clin North Am, 33, pp.237~252 (2007)
- Cohen-Solal JF, "Sex hormones and SLE: influencing the fate of autoreactive B cells", Curr Top Microbiol Immunol, 305, pp.67~88 (2006)
- Cortes-Hernandez J, "Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies", Rheumatology, 41, pp.643~650 (2002)
- Tincani A, "Animal models of antiphospholipid syndrome", Rev Rhum Engl Ed, 65, pp.614~618 (1998)
- Di Simone N, "Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I", Arthritis Rheum, 43, pp.140~150 (2000)
- Lojacono A, "Fetal stroke associated with maternal antiphospholipid antibodies: a case report", Lupus, 5, pp.512~ (1996)
- Magid MS, "Placental pathology in systemic lupus erythematosus: a prospective study", Am J Obstet Gynecol, 179, pp.226~234 (1998)
- Lima F, "Obstetric outcome in systemic lupus erythematosus", Semin Arthritis Rheum, 25, pp.184~192 (1995)
- Chakravarty EF, "Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis", Arthritis Rheum, 54, pp.899~907 (2006)
- Qazi UM, "Soluble FMS-like tyrosine kinase is a significant predictor of preeclampsia in SLE pregnancy", Arthritis Rheum, 54, pp.264~265 (2006)
- Khamashta MA, "Systemic lupus erythematosus flares during pregnancy", Rheum Dis Clin North Am, 23, pp.15~30 (1997)
- Buyon JP, "Neonatal lupus syndromes, In Systemic lupus erythematosus. 3rd ed", pp.337~359 (1999), Academic Press
- Baud O, "Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants", N Engl J Med, 341, pp.1190~1196 (1999)
- Costedoat-Chalumeau N, "Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group", Arthritis Rheum, 48, pp.3207~3211 (2003)
- Khamashta MA, "Systemic lupus erythematosus and pregnancy", Best Pract Res Clin Rheumatol, 20, pp.685~694 (2006)
- Petty RE, "Textbook of pediatric rheumatology. 5th ed", pp.342~406 (2005), WB Saunders Company
- Solomon BA, "Neonatal lupus erythematosus: discordant disease expression of U1RNP-positive antibodies in fraternal twins--is this a subset of neonatal lupus erythematosus or a new distinct syndrome", J Am Acad Dermatol, 32, pp.858~862 (1995)
- Brucato A, "Risk of congenital complete heart block in newborns of mothers with anti-Ro", SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women, 2001, pp.44, 1832~1835
- Saleeb S, "Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus", Arthritis Rheum, 42, pp.2335~2345 (1999)
- Ross G, "Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children", Arch Pediatr Adolesc Med, 157, pp.397~402 (2003)
- Mintz G, "Contraception with progestagens in systemic lupus erythematosus", Contraception, 30, pp.29~38 (1984)
- Hatcher RA, "Contraceptive technology. 18th ed" (2004), Ardent Media
- Petri M, "Combined oral contraceptives in women with systemic lupus erythematosus", N Engl J Med, 353, pp.2550~2558 (2005)
- Ho A, "A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus", Arthritis Rheum, 44, pp.2350~2357 (2001)
- Buyon JP, "Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy", Arthritis Rheum, 35, pp.55~61 (1992)
- Buyon JP, "Assessing disease activity in SLE patients during pregnancy", Lupus, 8, pp.677~684 (1999)
- Clowse MEB, "Complement and doublestranded DNA antibodies predict pregnancy outcomes in lupus patients", Arthritis Rheum, 50, pp.408~ (2004)
- Georgiou PE, "Outcome of lupus pregnancy: a controlled study", Rheumatology, 39, pp.1014~1019 (2000)
- Cavallasca JA, "Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE)", Clin Rheumatol, 27, pp.41~46 (2008)
- Kim SH, "Clinical sourse and pregnancy outcome in patients with systemic lupus erythematosus", Korean J Obstet Gynecol, 39, pp.1607~1616 (1996)
- 신정현, "전신성 홍반성 루푸스와 임신의 상호 영향에 대한 연구", 대한내과학회지, 65(5), pp.511~519 (2003), 대한내과학회
- 안현영, "전신성 홍반성 루푸스를 동반한 임산부 94예의 임신 경과 및 산과적 고찰", Obstetrics & Gynecology Science, 51(2), pp.147~157 (2008), 대한산부인과학회